Edward G. Lorenzana
24 works · 1,895 citations · h-index 10
Top works
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer
- Abstract 3790: Preclinical profile of LGX818: A potent and selective RAF kinase inhibitor
- Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth
- Differential Detection of Five Mouse-Infecting Helicobacter Species by Multiplex PCR
- Vemurafenib Cooperates with HPV to Promote Initiation of Cutaneous Tumors
- Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models
- RecombinantHelicobacter bilisProtein P167 for Mouse Serodiagnosis in a Multiplex Microbead Assay
- Discovery of Potent and Selective Antibody–Drug Conjugates with Eg5 Inhibitors through Linker and Payload Optimization
- Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia
- Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth
- Abstract 2837: Dual inhibition of SHP2 and CDK4/6 leads to immunological memory and immune-mediated anti-tumor activity in a mouse syngeneic model of breast cancer
- Abstract 1322: Maximizing the therapeutic potential of SHP2 inhibition with rational combination strategies in tumors driven by aberrant RAS-MAPK signaling
- DDIS-33. SELECTIVE AND COMPLETE INHIBITION OF mTORC1 BY BI-STERIC mTOR INHIBITORS DRIVES THERAPEUTIC RESPONSE IN GLIOBLASTOMA
- Data from Vemurafenib Cooperates with HPV to Promote Initiation of Cutaneous Tumors
- Abstract LB-61: Vemurafenib promotes RAS wild-type tumor formation in a mouse model of HPV-driven cutaneous squamous cell carcinoma.
- Author Correction: Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth
- Supplementary Figures 1 - 5 from Vemurafenib Cooperates with HPV to Promote Initiation of Cutaneous Tumors
- Data from Vemurafenib Cooperates with HPV to Promote Initiation of Cutaneous Tumors
- Abstract 1322: Maximizing the therapeutic potential of SHP2 inhibition with rational combination strategies in tumors driven by aberrant RAS-MAPK signaling